Targeting oxidative stress in embryonal rhabdomyosarcoma.
about
Rhabdomyosarcoma: Advances in Molecular and Cellular BiologyStructural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesPediatric solid tumor genomics and developmental pliancyRecent advances in understanding and managing rhabdomyosarcomaGermline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcomaPediatric Rhabdomyosarcoma.Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction.Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway.Genomic landscape of paediatric adrenocortical tumours.Clonality and evolutionary history of rhabdomyosarcomaA versatile modular vector system for rapid combinatorial mammalian geneticsMURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.Structural analysis of tumor-related single amino acid mutations in human MxA proteinProbing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies.Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer.Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcomaKey role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar RhabdomyosarcomaHepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.Myogenic regulatory transcription factors regulate growth in rhabdomyosarcomaAnaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.PAX genes in childhood oncogenesis: developmental biology gone awry?JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
P2860
Q26784207-86E6CE89-CD20-4337-989F-8F2D6EF51A65Q26991436-A4900359-D6E0-49A8-A81D-A6E20A85F3BEQ27023560-77FA9145-F1AB-4CEE-B431-525023C1F20BQ27024496-4808DA6E-EBAE-48D5-B8FD-3D4281B6900FQ33423823-12733764-4A1E-4C33-916B-0016F9E2B500Q33586736-DBD82494-2EB0-42D9-9A5F-3D0A453C871EQ33842070-931A860F-7F54-4376-AB22-B7C9ACBF6A90Q33872384-CE9E0D8B-2335-4D47-B2AF-D5D5F5A4FC44Q33881163-BA19FE81-8E44-47C3-8F6E-1445FCBC8C0DQ33970870-889336AA-64CC-4369-9520-509CCA9233DEQ34691553-39903742-2E6E-4960-A77D-BA0794AB5108Q35082747-474FDC71-5F2A-4073-8CB8-E4F5A64C5D25Q35156692-D628A236-37FE-44ED-BF7C-43DF09265F12Q35175269-7EB48E20-5A7E-43A5-93D1-45C9B09EC36EQ35408740-66A2149C-F1B3-4F36-AD38-3A127BE48EA8Q35667137-31505825-146E-4B3A-B4F0-34B44B9F7D4DQ35819280-1F6252C8-6926-4020-8E3C-569EF8A20C6CQ35861006-BF45E1CC-7CED-4256-832F-FB9073324665Q35863493-6C137EE6-53EA-4EBE-8C6C-93C8D71E826CQ36109294-3C537F61-2B17-47E0-B4C4-38DD0FBEBB00Q36121243-86BF0DF8-862B-438D-9FDD-06C3FBA015A1Q36142754-0CAF3619-2BDF-4574-B6A9-90ECC93F7333Q36201075-490D076C-EEB6-45A8-AB57-D74908F7676BQ36367000-1E927021-60C3-4C66-A61F-9FB222A312ECQ36378105-067269AF-A2EB-481E-8414-0DBEBCADC6DEQ36415118-0ED1376B-94B7-43DF-829A-0FC785D6301BQ36599973-533E6D86-9832-48BE-96E5-72BD6999960BQ36623378-54D73657-27EA-4558-94C1-41282E53F6D4Q36739725-E7078A7F-D299-43C3-99B9-7510B0709A9BQ37327724-5649C3C4-4F9F-4018-B847-AEFA886A965EQ37350775-0BCD88DD-EF95-4629-96B3-20D03F8882E3Q37482775-4032E946-9D40-47D3-92FA-40C887CEF2ACQ37549897-AD029487-6117-4047-B22B-9440D705D2CDQ37583178-0BA2B6C6-3709-4417-A1AB-397104AB6D19Q37644788-56E6BA6F-1688-46D9-8969-2BE3602C1E9EQ37702007-6075172C-C8AB-4BBA-B04E-F1EF111D2224Q38231866-91D53039-F19C-4E93-B8F3-702282773AFFQ38262101-D8A237B0-DE06-4641-9277-C67BA794AE3FQ38297328-674CCBC3-20A7-4E4B-897A-51C671090F46Q38373823-49CA427C-5085-4895-9889-4F5E33EDDEB5
P2860
Targeting oxidative stress in embryonal rhabdomyosarcoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting oxidative stress in embryonal rhabdomyosarcoma.
@en
type
label
Targeting oxidative stress in embryonal rhabdomyosarcoma.
@en
prefLabel
Targeting oxidative stress in embryonal rhabdomyosarcoma.
@en
P2093
P2860
P50
P1433
P1476
Targeting oxidative stress in embryonal rhabdomyosarcoma
@en
P2093
Alberto Pappo
Andrew M Davidoff
Armita Bahrami
Charles Lu
Chris Morton
Cori Bradley
David Finkelstein
Donald Yergeau
Douglas S Hawkins
P2860
P304
P356
10.1016/J.CCR.2013.11.002
P577
2013-12-01T00:00:00Z